updated - September 25, 2020 Friday EDT
The Oracle Corporation has just announced that it has signed an agreement to acquire Maxymiser, a leading provider of cloud-based software, according to Oracle’s press release that is published in Market Watch.
Liberty Interactive Corporation, the owner of home shopping network QVC, has just announced that they have reached an agreement to acquire Zulily, Inc. for approximately $2.4 billion, or $18.75 per share in cash and stock, according to a press release issued by Liberty.
Goldman Sachs Bank USA has announced that it will be acquiring GE Capital Bank’s online deposit platform and assume GE’s $8 billion in online deposits and $8 billion in brokered certificates of deposit, according to a press release issued by Goldman Sachs.
Roche has just announced that it will be acquiring GeneWEAVE Biosciences, Inc., a privately held company focused on innovative, clinical microbiology diagnostics solutions, for approximately $425 million, according to a press release issued by Roche.
Fidelity National Information Services, Inc. (FIS) has just announced that it has signed a “definitive agreement” to acquire SunGard Data Systems, Inc., one of the world’s leading financial software companies, for $9.1 billion, according to a press release issued by FIS.
The Carlyle Group LP, a global alternative asset manager, has announced that it has agreed to acquire Veritas, an information management systems provider, from Symantec Corporation for $8 billion in cash, according to a press release issued by Carlyle.
Envestnet, Inc. a leading provider of unified wealth management technology and services to financial advisors has announced that it will acquire Yodlee, Inc. for approximately $590 million, according to a press release issued by the company.
Cancer Genetics, Inc. has announced that it has entered into an agreement in principle to acquire Response Genetics, Inc., a CLIA-certified clinical laboratory focused on the development and sale of molecular diagnostic testing services for cancer, according to a press release issued by Cancer Genetics.
Mallinckrodt Plc, has entered into a “definitive agreement” with The Gores Group LLC for a subsidiary of Mallinckrodt to acquire Therakos, Inc., a leading immunotherapy company, for approximately $1.325 billion, according to press release issued by Mallinckrodt.